bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.06.13.732027

Whos been sleeping in my bedroom? Sleep and cardiorespiratory physiology when co-sleeping with a dog, cat, or child

Abstract

Co-sleeping with pets or children is common, yet its effects on sleep, cardiorespiratory physiology, and behavioral outcomes are understudied. We examined within-person associations between co-sleeping with a dog, cat, or child and sleep characteristics, measures of cardiorespiratory physiology, and next-day physical activity in 1,649,083 person-days from 11,733 adults wearing the WHOOP wearable device. Participants reported nightly co-sleeping via a daily journal in the devices companion smartphone application, and linear mixed-effects models compared nights with and without co-sleeping within the same individual. Co-sleeping was associated with modest improvements in cardiorespiratory physiology, including lower resting heart rate (0.8-1.1 beats/min), lower respiratory rate (0.04-0.07 breaths/min), and higher heart rate variability (1.41-1.95 ms). Sleep outcomes were mixed, with longer sleep duration (5.5-9.6 min) but more disturbances (0.36-0.40 instances) and slightly less restorative sleep (0.23-1.17%). Associations were generally consistent across groups, although child co-sleeping showed greater sleep disruption. Next-day physical activity was higher following dog and cat co-sleeping (7.6 and 7.4 intensity-weighted min, respectively) but lower following child co-sleeping (2.6 intensity-weighted min). Although effect sizes were small ({beta} range: 0.008-0.045), findings suggest that co-sleeping is associated with a trade-off between modest cardiorespiratory benefits and mild sleep disruption, indicating that co-sleeping decisions may be driven more by personal and contextual factors than by concerns about physiologic impact.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Montoye, A. H., Curran, D., Grosicki, G. J.. 2026-06-17. Whos been sleeping in my bedroom? Sleep and cardiorespiratory physiology when co-sleeping with a dog, cat, or child. https://doi.org/10.64898/2026.06.13.732027

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rad and Phospholamban are Key Drivers of the Ventricular Adrenergic Response and Stress-Induced Arrhythmia

The adrenergic response is a fundamental mechanism that regulates heart rate (chronotropy), cardiac contractility (inotropy) and relaxation (lusitropy). Adrenergic stress is also a recognized trigger of arrhythmia in disease. Yet, our understanding of the underlying molecular basis remains incomplete. Protein kinase A (PKA) and the calcium/calmodulin-dependent kinase II (CaMKII) phosphorylate multiple targets proposed to participate in the adrenergic response, including the GTP-binding protein Rad, phospholamban (PLB) and ryanodine receptor 2 (RyR2). Here we demonstrate that phosphorylation of both Rad and PLB is necessary for inotropy and lusitropy. We show that changes in cardiac contractility and relaxation are primarily dependent on intracellular calcium handling. Finally, we report that Rad and PLB control stress-induced arrhythmogenesis, despite the phosphorylation of other pro-arrhythmic targets. We have identified the essential molecular components of the adrenergic response, resolving a long-standing debate in cardiac excitation-contraction coupling and refining current models of sympathetic regulation in health and disease.

physiology↗

MCT6 is an intestinal Lac-Phe exporter required for metformin-associated weight loss

Metabolites are increasingly recognized as circulating molecules that regulate physiology, yet the mechanisms that couple intracellular production to organism-wide action remain poorly defined. Using the anorexigenic metabolite Lac-Phe as a tractable system, we identify the orphan transporter MCT6 (SLC16A5) as a physiologic intestinal Lac-Phe exporter. This mechanism controls the extent to which intracellularly synthesized Lac-Phe acquires systemic activity. MCT6 transports Lac-Phe, mediates its cellular efflux, and is required for maintaining its blood levels in mice following strong glycolytic stimuli. Both global and intestinal epithelial-specific deletion of MCT6 confers resistance to metformin-associated weight loss on a high-fat diet. Bypassing the transport defect with exogenous Lac-Phe normalizes the body weight phenotype of MCT6-KO mice. Together, these data connect MCT6 to metformin pharmacology and intestinal lactate metabolism, and more generally underscore the importance of transporter-mediated release in the conversion of an intracellular metabolic state into a circulating metabolite effector.

physiology↗

DEPP1 connects nutrient and oxygen availability to maintenance of muscle mass

Nutrients and oxygen are sensed within the muscle to control growth and disruption of either signal is sufficient to lead to muscle atrophy. While nutrient limitation is sensed via a conserved transcriptional atrophy program (commonly referred to as atrogenes) dictated via the Forkhead box O (FoxO) transcription factors, how low oxygen promotes muscle loss remains unknown. Accordingly, the downstream mechanisms that initiate muscle loss when oxygen and nutrients are limiting are only partly understood. Here, we find Hypoxia Inducible Factor (HIF), the master regulator of our adaptation to low oxygen, is necessary and sufficient to mediate muscle loss under hypoxia in mice. RNA sequencing in skeletal muscle isolated from starved or hypoxic mice identifies Decidual Protein Induced by Progesterone 1 (Depp1), which is induced in skeletal muscle when nutrients or oxygen is limiting via FoxO1 and HIF activation, respectively. Whole body Depp1 loss in mice reduces muscle loss under fasting and hypoxia and skeletal muscle Depp1 overexpression is sufficient to mediate muscle atrophy. Mechanistically, Depp1 localizes to the mitochondria and is necessary to control autophagy activation and mitochondrial degradation in skeletal muscle. Taken together, our studies nominate Depp1 as a new atrogene necessary for muscle loss under multiple atrophy scenarios involving FoxO and HIF.

physiology↗